News Release

Novel research aims to identify new medications for the treatment of opioid use disorder

Peer-Reviewed Publication

University of Pennsylvania School of Nursing

PHILADELPHIA (OCTOBER 31, 2019) - Opioid use disorder and overdose deaths are a major public health crisis in the United States. While medication-assisted treatments for opioid use disorder exist, these treatments remain inadequate for many patients, resulting in a high rate of relapse following detoxification.

A new study from the University of Pennsylvania School of Nursing (Penn Nursing) shows the first evidence supporting a role for glucagon-like peptide-1 (GLP-1) receptor agonists in opioid reinforcement and analgesic responses. Using recently established models of opioid-taking and -seeking behaviors in rats, researchers have shown that systemic administration of the GLP-1 receptor agonist exendin-4 reduced oxycodone self-administration and the reinstatement of oxycodone-seeking behavior, an animal model of relapse.

"Collectively, these findings highlight a novel role for GLP-1 receptors in opioid mediated behaviors and suggest that central GLP-1 receptors could serve as targets for novel medications aimed at treating opioid use disorder without affecting opioid-induced analgesic responses," said Yafang Zhang, a post-doctoral fellow at Penn Nursing and lead investigator of the study.

The study, "Activation of GLP-1 Receptors Attenuates Oxycodone Taking and Seeking Without Compromising the Antinociceptive Effects of Oxycodone in Rats" has been published in the journal Neuropsychopharmacology.

Co-authors of the article include Michelle W. Kahng, Jaclynn A. Elkind and Vanessa R. Weir, all of Penn Nursing; and Nicole S. Hernandez and Lauren M. Stein, both of the University of Pennsylvania Perelman School of Medicine. Senior author Heath D. Schmidt, PhD, is an Associate Professor of Nursing in Penn Nursing's Department of Biobehavioral Health and an Associate Professor of Psychiatry in Penn's Perelman School of Medicine.

###

The research was supported by a grant from the National Institutes of Health, R01 DA037897, as well as grants from the Center for Undergraduate Research & Fellowships and the Office of Nursing Research at Penn Nursing.

About the University of Pennsylvania School of Nursing

The University of Pennsylvania School of Nursing is one of the world's leading schools of nursing. For the fourth year in a row, it is ranked the #1 nursing school in the world by QS University and is consistently ranked highly in the U.S. News & World Report annual list of best graduate schools. Penn Nursing is currently ranked # 1 in funding from the National Institutes of Health, among other schools of nursing, for the second consecutive year. Penn Nursing prepares nurse scientists and nurse leaders to meet the health needs of a global society through innovation in research, education, and practice. Follow Penn Nursing on: Facebook, Twitter, LinkedIn, & Instagram.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.